Vivos Therapeutics, Inc.VVOS

$0.50-0.01 (-2.19%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$7M
Micro-cap
-91%
2020 — today
10-Year Price
-100%
2020 — today
52-Week Range
$0.50$6.95
Current $0.50· 0%

Vivos Therapeutics, Inc. is a medical technology enterprise dedicated to developing and commercializing advanced treatment solutions for adults facing conditions like dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring. The company's flagship product, the Vivos System, offers a unique multi-disciplinary therapy that stands out for being non-invasive, non-surgical, and free of pharmaceuticals, specifically addressing these dentofacial and sleep-related issues. Additionally, Vivos Therapeutics provides the VivoScore Program, a service encompassing comprehensive screening and convenient home sleep tests for both adults and children. The Vivos System is distributed and sold to licensed medical professionals, primarily general dentists, across the United States and Canada. Founded in 2016, Vivos Therapeutics, Inc. maintains its headquarters in Highlands Ranch, Colorado.

Valuation in context

P/E ratio
-0.2
N/A
Not meaningful — company is unprofitable
P/B ratio
-5.8
N/A
Not meaningful — company is unprofitable
FCF Yield
-249.4%
Near historic low
Near historic low — last 10 years
Free · No credit card needed

Get alerted when VVOS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.